Developing Cellular Therapies for Stroke - Wikidata - wikimedia - TriplyDB

Developing Cellular Therapies for Stroke

Developing Cellular Therapies for Stroke

http://www.wikidata.org/entity/Q28087451

about

Poststroke Cell Therapy of the Aged Brain Adult Stem Cell Therapy for Stroke: Challenges and Progress Systematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke.Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells Promoting recovery from ischemic stroke.TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke.Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacy.The Current State of Cell Therapies for Cerebrovascular Diseases.Update on cell therapy for stroke Stroke: Basic and Clinical.Intravenously Transplanted Human Bone Marrow Endothelial Progenitor Cells Engraft Within Brain Capillaries, Preserve Mitochondrial Morphology, and Display Pinocytotic Activity Toward Blood-Brain Barrier Repair in Ischemic Stroke Rats.CFHR1-Modified Neural Stem Cells Ameliorated Brain Injury in a Mouse Model of Neuromyelitis Optica Spectrum Disorders.

P2860

Q26782735-04186041-377A-48C7-A0F2-628117B52951 Q28066235-2262E8E1-C5CC-41FA-85A0-ADEE4B000195 Q30387946-2532675C-90B4-49A7-902A-84E43BD1E6C8 Q37249928-1E0226F8-D6B1-4435-8564-B665D9DDD241 Q38675024-00D70ED2-ABF8-4497-850C-D49EAC233A89 Q38888000-DDB9A40C-B0DA-494E-93F9-7384401145FD Q39039084-233E12CF-6B7B-4F5D-B58E-EF7514EEB673 Q41147000-A411810A-1C34-4C6E-807D-DBC66626EA95 Q41678510-050FFCC9-BE59-43E1-8907-B57F10AA4B71 Q47310998-D54A2FB9-6962-47C1-9D6F-2618356DFFD7 Q48331191-337BDABE-50F8-4F1F-8FAC-87C11A680CAC Q48334547-D86E110B-21EA-4A63-97B0-988FB0406A08

P2860

Developing Cellular Therapies for Stroke

http://www.wikidata.org/entity/Q28087451

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Developing Cellular Therapies for Stroke

@ast

Developing Cellular Therapies for Stroke

@en

Developing Cellular Therapies for Stroke

@nl

type

label

Developing Cellular Therapies for Stroke

@ast

Developing Cellular Therapies for Stroke

@en

Developing Cellular Therapies for Stroke

@nl

prefLabel

Developing Cellular Therapies for Stroke

@ast

Developing Cellular Therapies for Stroke

@en

Developing Cellular Therapies for Stroke

@nl

P1433

Q28087451-775E7DFE-7695-4586-B2EA-76A46441C57F

P1476

Q28087451-C815C2CE-732F-4098-8E7C-C1F3380C06E5

P2093

Q28087451-DF120245-65D7-4742-A311-B9DACD79EF01

P2860

Q28087451-0016F262-AE3D-4DDF-A110-571FC4C9CABF

Q28087451-174A97FC-726B-4148-A36D-2F049D4EEF30

Q28087451-1AAC0CE4-BDB0-460B-A22B-F5ACFF011AAF

Q28087451-1FB8BE7C-D4E8-4CF0-B09D-61A24C702D81

Q28087451-243040FE-C5E3-45BC-8022-53B7D6566301

Q28087451-30133935-CFF2-437F-A07A-08C779EC264F

Q28087451-38F7DB42-BACD-46DF-A2E2-5C3396E36E31

Q28087451-3D6A3623-D300-435A-BF2B-7FF823F48FB6

Q28087451-45ED4B19-6EAA-457C-ADF8-4113CA74D592

Q28087451-48FB2424-05CE-4923-A0F1-54BB811C3275

P304

Q28087451-0E85AA7B-F04A-467B-87EA-A0C6119141CB

P31

Q28087451-43C3CBE4-3E64-43AE-82DC-6D5C220ED88D

P3181

Q28087451-AE649937-13D9-4FD0-AF98-E6703D560BA7

P356

Q28087451-690B776C-C2D2-438C-8832-E073D30527E3

P407

Q28087451-589449B3-D2EA-4D3B-A582-6386C461B4F2

P433

Q28087451-A004FA8F-9533-4479-9E69-26D5936C1B90

P478

Q28087451-2FDD2E28-5FC9-4EC1-9BE1-142E7A549A50

P577

Q28087451-4D530863-1614-45C1-9DE5-D67330D9DED8

P698

Q28087451-E16306DE-DB9D-49C1-9CB5-E9A560850FE3

P932

Q28087451-959FA4D2-7598-449C-AC8D-B4C8399C8BA6

P3181

P356

STROKEAHA.115.007149

P1433

P1476

Developing Cellular Therapies for Stroke

@en

P2093

Sean I. Savitz

http://www.w3.org/2001/XMLSchema#string

P2860

Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect

Update of the stroke therapy academic industry roundtable preclinical recommendations

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

The immunology of stroke: from mechanisms to translation

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis.

Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia

Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow.

Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes

Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury.

P304

2026-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3242902

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/STROKEAHA.115.007149

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26045599

http://www.w3.org/2001/XMLSchema#string

P932

4479962

http://www.w3.org/2001/XMLSchema#string